Jessica J. Federer

Jessica J. Federer is a prominent figure in the life sciences and health technology sectors, currently serving as a Senior External Advisor at McKinsey & Company. Based in New York City, she has an extensive background in digital transformation and strategic leadership within the pharmaceutical industry.

Professional Background

• Current Roles:

  • Senior External Advisor, McKinsey & Company
  • Managing Partner, Supernode Ventures (since August 2022)
  • Strategic Advisor, WHAM Investment Collaborative (2024)

• Previous Experience:

  • Chief Digital Officer (CDO) at Bayer AG (2008-2017), where she led the company's global digital transformation across various divisions including Pharmaceuticals and Crop Science.134
  • Program Analyst at the U.S. Department of Health and Human Services (2005-2006) where she began her career in public health.13

Board Memberships and Advisory Roles

Jessica serves on several boards, including:

• Sage Therapeutics
• Pluto Health
• Aspivix
• Angelini Ventures (investing in biotech and digital health)
  She is also involved with the Yale Ventures Blavatnik board and has previously served on the United Nations ITU advisory board.234

Education

Federer holds a Bachelor of Science from George Washington University and a Master of Public Health from Yale University.34

Recognition

She has been recognized as one of the top Chief Digital Officers in the healthcare sector and was named a 2023 "Icon" by Rock Health for her contributions to health equity.34 Her leadership is particularly noted for advancing investment initiatives in women's health through her role at WHAM, where she emphasizes addressing significant health disparities affecting women.2

Overall, Jessica J. Federer is a key leader in leveraging technology to drive advancements in healthcare, particularly focusing on women's health issues and digital innovation within the life sciences industry.